Epithelial-derived interleukin-23 promotes oral mucosal immunopathology
At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the...
Gespeichert in:
Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 2024-04, Vol.57 (4), p.859-875.e11 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.
[Display omitted]
•Epithelial IL-23 is evident in patients with common and Mendelian forms of periodontitis•Non-hematopoietic-cell-derived IL-23 is a pathogenic driver in experimental periodontitis•Flagellated microbes induce epithelial IL-23 through canonical TLR5 signaling•Epithelial IL-23 is evident across human barrier tissues and increased in Th17 diseases
Epithelial cells at mucosal surfaces provide a structural barrier and an immune defense system, but dysregulated epithelial responses can contribute to disease. Kim et al. reveal that epithelial-derived IL-23 is a pathogenic trigger in the oral mucosal disease periodontitis. Moreover, their findings suggest a broader role for epithelial-derived IL-23 in human Th17-mediated inflammatory diseases across barrier tissues. |
---|---|
ISSN: | 1074-7613 1097-4180 1097-4180 |
DOI: | 10.1016/j.immuni.2024.02.020 |